MedPath

Evaluation of efficacy of gokshuradi gutika in diabetic kidney disease-an open clinical trial

Phase 3
Conditions
Health Condition 1: null- Stable type 2 DMmicroalbuinuria between 30 to 300 mcg/24 hours40-80 years of age of either sexHealth Condition 2: E112- Type 2 diabetes mellitus with kidney complications
Registration Number
CTRI/2018/07/015042
Lead Sponsor
KAHERS Shri B M kankanwadi ayurveda mahavidyalaya and ayurveda hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Stable type 2 Diabetes mellitus

Microalbuminuria 30-300 micrograms/24 hours

40-80 years of age of an either sex

Exclusion Criteria

The patients having any other complications of diabetes such as cardiomyopathy, hyperkalemia and other uremic symptoms.

Patients having other systemic disorders which interfere with the course of treatment.

The patient who are febrile, having recurrent UTI, marked hypertension.

Pregnant and lactation female subjects

The patient who are on ACE inhibitors and ARB medicines.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of gokshuradi gutika on incipient diabetic nephropathy (micro albuminuriaTimepoint: On the first visit Day 0 <br/ ><br>On third visit Day 60
Secondary Outcome Measures
NameTimeMethod
OT APPLICABLETimepoint: NOT APPLICABLE
© Copyright 2025. All Rights Reserved by MedPath